Oxford Biodynamics Plc

-1.40 (-10.41%)
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biodynamics Plc LSE:OBD London Ordinary Share GB00BD5H8572 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -1.40 -10.41% 12.05 366,148 10:58:39
Bid Price Offer Price High Price Low Price Open Price
12.05 13.25 13.05 12.05 13.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Biological Pds,ex Diagnstics 0.51 -6.71 -6.70 - 12.09
Last Trade Time Trade Type Trade Size Trade Price Currency
11:42:01 O 20,000 12.5036 GBX

Oxford Biodynamics (OBD) Latest News

Oxford Biodynamics (OBD) Discussions and Chat

Oxford Biodynamics Forums and Chat

Date Time Title Posts
31/5/202307:52Oxford BioDynamics PLC620
17/2/202211:29OBD-23/03/21-110P-SP might go up exponentially given the potential in the US12

Add a New Thread

Oxford Biodynamics (OBD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Oxford Biodynamics (OBD) Top Chat Posts

Top Posts
Posted at 24/4/2023 10:37 by badger60
I should imagine that such a comprehensive test needs approval from the FDA etc. in terms of viability and also safety.Of course, no mention of that.....just OBD rhetoric telling us that they are swamped out with orders......in reality for something that doesn't exist..........
Posted at 14/4/2023 01:08 by badger60
Oh dear....perhaps OBD should have thought twice before shelling out on their new 7800 sq ft facility. Still no mention of specific meaningful firm revenue generating orders yet. I wonder why that is?
Posted at 06/4/2023 19:50 by rod11mac
I'm surprised that there has been no market reaction nor anything on this bb to yesterday's rns on amongst other things the PSE test and specifically mobilisation to build testing facilities.
This has got to be a game-changer in the fight against prostate cancer, and if so, a big winner for OBD.
So what am I not seeing?

Posted at 04/4/2023 05:35 by badger60
They'll need another fundraiser before year end if/when no profitable revenue is forthcoming. In the meantime the share price is creeping up....but still 5-6p lower than the inflated 20pps fundraiser last October.
The annual cash burn is probably higher than the 7 Mio+ as they try to put more effort into to kickstarting this donkey.
No substantive progress RNS for a long time re sales or revenue. So far it's been a donkey in both the US and UK.
I notice that Hoyer Miller, the founding CEO has reduced his position.
Considering it came to the market at well over a quid a share, and peaked at 3 quid valuing it at over 250 Mio, the current issuance is now close on 150 mio, valuing the dog at about 21 Mio.
News of substance should improve the share price ..,......but there isn't any......

Posted at 21/3/2023 15:18 by stablehound
The frustration of this Company is that nothing tangible ever seems to happen but some brave souls are still prepared to stump up further cash at a generouse price; so someone somewhere knows something that we, the poor bloody infantry, are not yet allowed to know. We shall no doubt learn something at the end of this month but if there is something on pop ups on the Company website can this not be shared here?

If the CEO finally has sufficent confidence to buy shares with his own money then that is a positive indicator; if the CFO were preparted to do the same thing we could see some action on the share price

Posted at 23/2/2023 10:44 by smackeraim
Oxford BioDynamics Plc (AIM: OBD) announces that it has received notice that Dr Jon Burrows, the Group's Chief Executive Officer and an Executive Director, has purchased 50,000 Ordinary Shares of 1 pence each ("shares") at an average price of 20p per share.
Posted at 06/2/2023 12:32 by badger60
Considering that the share price hit 300p in 2017 not long after coming to the market...... valuing the company at a ridiculous 250 mio......one has to ask the question why it still has an annual cash burn of circa 8 Mio pa and produces no revenue...... despite ongoing tissues of hype, lies and promises to the contrary from the OBD management.
Posted at 30/1/2023 12:08 by andymunchkin
badger6026 Jan '22 - 16:24 - 323 of 570
0 0 0
Dear oh dear...not looked in here for some time but the share price was well into 3 figures...maybe even 200p+.........wtf's happened???
Another death by Diggle share. What with PRM, and Oxb seriously nosediving......OBD must be doing a PRM deja vu.

PRM peaked at 240pps in 2003... currently "trading" at 4 and a bit p..... Looks like OBD is running down the same railroad track..
geTSmacked 1opCummIngs

Posted at 14/12/2022 11:32 by elpirata
Dont expect anything to change share price wise until they rns the £££ numbers showing the Episwitch CiRT uptake whenever that might be. They must have talked a good game getting the placing away at a material premium.
Posted at 22/10/2022 11:34 by badger60
elpiritaWell done...... anything Diggle related should be as risk free as possible.....just look at his jewel in the crown OXB. Peaked at 16+ quid ps a year ago......today 3 quid ps.OBD actually traded at 10.5p and was 12p only a couple of weeks ago. What I can't believe is that soon after being launched in the mid 100's, they ramped it up to 3 quid on hot air.( Mkt cap inxs of 250 Mio ffs!!) Whether the product is any good or not I can't say, but they are only a chancer company and their tests are usd3500 to buy. They had little if any response in the US, and "launched" it in the UK a few weeks back.( Same response..."plenty of interest"...but not selling many, if any). As regarding the take-up.....the share price hasn't exactly done anything to impress. Give it a bit more time and it'll drop off, imo.(as soon as Diggle stops supporting it).If he ramps it....... it's well worth a sell and take the profit.....but you know that already.
Oxford Biodynamics share price data is direct from the London Stock Exchange
Your Recent History
Oxford Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230609 11:31:41